Review explores TRIM protein roles in HIV pathogenesis and potential therapeutic targetsReview explores how TRIM proteins might help fight advanced HIV infection

This systematic review examines the roles of TRIM proteins in the pathologic progression of advanced HIV infection, focusing on HIV-1 invasion, long terminal transcription inhibition, and nonhistone protein reversible ubiquitination. The review synthesizes evidence on how these proteins participate in host defense against viral infection through diverse molecular mechanisms. The analysis describes interactions with the NF-κB pathway, JAK-STAT pathway, RLR/MDA5 pathway, and IRF pathway, as well as the induction of premature degradation of viral proteins.

No specific study population, sample size, setting, intervention, comparator, or outcomes are reported in the available data. The review represents a synthesis of basic science research exploring molecular mechanisms rather than clinical trial data. No patient outcomes, safety information, or clinical efficacy data are presented.

Key limitations include the absence of clinical trial data, patient outcomes, safety information, and specific study details. The review focuses on molecular mechanisms and potential therapeutic targets without providing evidence of clinical application or effectiveness. The practice relevance is limited to theoretical understanding of HIV pathogenesis mechanisms rather than direct clinical application.

This review provides foundational knowledge about TRIM protein functions in HIV infection but offers no clinical guidance for patient management. Healthcare providers should recognize this as basic science research that identifies potential therapeutic targets requiring clinical validation through future studies.